Posted by Michael Wonder on 27 Jan 2021
Alleviant Medical receives breakthrough device designation from FDA for transcatheter technology
25 January 2021 - Alleviant Medical today announced that the US FDA has granted the company a breakthrough device designation for its transcatheter technology.
The technology offers a no-implant interatrial shunt therapy for patients suffering from heart failure with preserved and mid-range ejection fraction who remain symptomatic despite optimal guideline directed medical therapy.
